Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 403 of 6351
-
Stem cells may replace painful bone graft for kids with cleft lip
Disease control Not yet recruitingThe objective of this study is to compare the safety and efficacy of a bone tissue engineering kit - composed of 10⁶ autologous mesenchymal stem cells derived from deciduous dental pulp combined with Bio-Oss® Collagen - with secondary autogenous iliac crest bone grafting for alve…
Phase 3 • Sponsor: Instituto de Tecnologia do Paraná • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a single dose of MDMA supercharge PTSD therapy?
Symptom relief Recruiting nowThe goal of this clinical trial is to investigate the efficacy of 3,4-methylenedioxy-methamphetamine hydrochloride (MDMA) combined with Massed Prolonged Exposure (PE) therapy for the treatment of posttraumatic stress disorder (PTSD) in adult participants diagnosed with PTSD. This…
Phase 2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New eye injection could mean fewer doctor visits for wet AMD patients
Disease control Not yet recruitingThe goal of this study is to evaluate whether AIV007 provides benefits to patients with neovascular age-related macular degeneration in improving vision and that it has an acceptable safety profile. Participants will receive either a periocular injection of AIV007 or intravitrea…
Phase 2 • Sponsor: AiViva BioPharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug ZG006 takes on chemo in advanced cancer battle
Disease control Not yet recruitingThis Phase III, multicenter, randomized, open-label, controlled study is designed to assess the efficacy and safety of ZG006 versus investigator-selected chemotherapy in participants with DLL3-positive advanced neuroendocrine carcinoma who have received prior systemic therapy.
Phase 3 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New liver support protocol could help patients avoid transplant
Disease control Not yet recruitingClinical trial The goal of this clinical trial is to learn if a liver support protocol works to treat Liver failure in adults. The main questions it aims to answer are: * Does hemoadsorption plus half-dose plasma exchange provide support to liver failure patients until recovery…
Sponsor: Unidade Local de Saude do Nordeste • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study is to assess the efficacy and safety of Lisaftoclax for prevention of DS in APL patients undergoing ATRA/ATO induction regimen.
Phase 2/3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to delay dialysis and save hearts in kidney patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group and event-driven phase III clinical trial. The aim of this trial is to confirm the superiority of HRS-7535 over placebo in reducing the risks of renal outcomes and cardiovascular death among parti…
Phase 3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a neck surgery slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis is a multicenter, prospective, open-label, endpoint-blinded randomized controlled clinical study. We aim to evaluate the safety and efficacy of deep cervical lymphovenous anastomosis (LVA) combined with routine treatment for patients with moderate Alzheimer's disease, compar…
Sponsor: Southwest Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New blood test could prevent dangerous delays in preeclampsia deliveries
Disease control Not yet recruitingPreeclampsia is a serious pregnancy complication caused by abnormal placental development and function. It can lead to high blood pressure and damage to organs such as the liver, kidneys, brain, or cardiovascular system. In these cases, the only definitive treatment is delivery. …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Which sedative best protects the brain after injury? trial pits three common drugs Head-to-Head
Disease control Not yet recruitingThe goal of this clinical trial is to compare the effects of propofol, midazolam, and dexmedetomidine on intracranial pressure control and clinical outcomes in adults with moderate-to-severe traumatic brain injury undergoing urgent neurosurgical intervention. The main questions …
Sponsor: Aswan University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New Once-Daily pill aims to tame ADHD symptoms in korean youth
Disease control Not yet recruitingThis is a Phase 3, randomized, double-blind, placebo-controlled, multicenter bridging clinical trial designed to evaluate the efficacy and safety of viloxazine extended-release capsules (AK-D101) compared with placebo in Korean children and adolescents aged 6 to 17 years with att…
Phase 3 • Sponsor: Alvogen Korea • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Smart breathing machines at home could cut hospital visits for COPD patients
Disease control Not yet recruitingThe purpose of this study is to evaluate the effectiveness and clinical efficiency of combining home non-invasive ventilation (NIV) with a continuous remote telemonitoring (TM) system in patients with Chronic Obstructive Pulmonary Disease (COPD) and persistent hypercapnia. In sta…
Sponsor: Air Liquide Healthcare Spain • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Diabetes drug may ease dangerous fluid retention in liver disease
Disease control Recruiting nowThis study aims to evaluate beneficial effects of using dapagliflozin in cirrhotic chronic liver disease patients. We hypnotized that the use of dapagliflozin will be associated with fewer need for large volume paracentesis hence better control of ascites, fewer need for ICU admi…
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal pain pump may offer relief for cancer patients when opioids fail
Symptom relief Recruiting nowApproximately 66% of patients with advanced cancer experience pain, which is often inadequately controlled and associated with a decline in health-related quality of life (HRQoL). Conventional pharmacologic management, ranging from simple analgesics to strong opioids, is frequent…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New drug duo targets hard-to-treat HER2 cancers
Disease control Not yet recruitingThis study is a multicenter, non-randomized, open-label, Phase Ib/II combination therapy trial. The trial consists of two parts: Part 1 (Phase Ib), dose-escalation of combination therapy, followed by Part 2 (Phase II), tumor-type exploration of combination therapy. This study wil…
Phase 1/2 • Sponsor: Suzhou Biomissile Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Diabetes drug shows promise for repairing damaged nerves
Disease control Not yet recruitingTirzepatide is a dual agonist of GLP-1 Receptor and the GIP receptor, producing substantial improvement in glycaemic control, weight reduction and insulin sensitivity. Beyond its metabolic effects, incretin signalling has demonstrated neuroprotective and neurotropic properties, i…
Phase 4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can removing bladder tumors in one piece improve cancer outcomes?
Disease control Not yet recruitingThis is a prospective, multi-centre randomised trial comparing between cTURBT plus 1-year BCG therapy, and ERBT plus 1-year BCG therapy, in patients with intermediate-risk or high-risk NMIBC.
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
Disease control Not yet recruitingThis multicenter, three-arm randomized controlled trial will evaluate the effects of early time-restricted eating and staple food reduction, each combined with an app-supported exercise intervention, on body weight and glycemic control among adults with obesity and abnormal gluco…
Sponsor: Peking University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can Mind-Body pilates outperform biofeedback for back pain?
Symptom relief Not yet recruitingChronic Non-Specific Low Back Pain means pain in the lower back that lasts for more than 3 months and does not have a serious cause like a fracture, infection, or nerve damage. It is very common and affects many people at some point in their lives. This type of back pain usually…
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Robots vs. hands: a precision showdown for hip fracture surgery
Disease control Recruiting nowThe goal of this clinical trial is to compare the clinical effectiveness and safety of robot-assisted autonomous closed reduction versus traditional manual closed reduction in adult patients aged 18 to 80 years with acute, closed intertrochanteric femoral fractures (Arbeitsgemein…
Sponsor: Beijing Jishuitan Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC